  
重金屬對DRE-CALUX抑制作用之研究 
 
 
摘要 
 
本研究目的是利用成本低、快速，及有效率的戴奧辛生物檢測技術 - DRE-Luciferase 
bioassay 來探討無機和有機重金屬對 2,3,7,8-tetrachlorinated dibenzo-p-dioxn (2,3,7,8-TCDD)活
化芳香烴碳氫化合物受器(Aryl Hydrocarbon Rreceptor, AhR)誘發螢火蟲發光酵素表現及
CYP1A1 酵素活性表現之影響。實驗中我們以 1 nM 2,3,7,8-TCDD 與不同濃度（0.001-100 μM）
之單一重金屬(NaAsO2, CdCl2, CrO3, HgCl2, PbCl2, AsCH3, As(CH3)2, HgCH3 及 Pb(C2H5)4)定量
加入 Huh7-DRE-Luc 細胞株中共同處理 24 小時，之後量測由 AhR 調控產生的螢火蟲發光酵
素經反應所產生的冷光反應及 EROD 活性。由實驗設計法結果得知處理單一無機金屬對
2,3,7,8-TCDD(1nM)活化 AhR 調控螢火蟲發光基因影響程度以 Cr(1μM) > As(1μM) > Pb(1μM) 
> Cd(0.1μM) ≧ Hg(1μM)且皆屬於負影響，而處理單一有機金屬對 2,3,7,8-TCDD(1nM)活化
AhR 調控螢火蟲發光基因影響程度以 AsCH3(1μM) > As(CH3)2(1μM) > HgCH3(0.1μM) > 
Pb(C2H5)4(1μM)且皆亦屬於負影響。MTT assay 中，NaAsO2, CdCl2, CrO3, HgCH3 在濃度高於
10-5M 時，對細胞毒性增加，存活率明顯下降，而有機重金屬相對於無機重金屬對螢火蟲發
光酵素表現及 CYP1A1 酵素活性的表現影響較小，其抑制效果最低約下降至控制組反應活性
的 60%左右，對 NaAsO2 及 PbCl2 其抑制效果顯著，可下降至控制組反應活性的 20%以下，
對任一測試金屬，隨著重金屬的濃度增加對 2,3,7,8-TCDD 活化 AhR 調控螢火蟲發光酵素的
表現及 CYP1A1 酵素活性的表現皆呈現下降趨勢。因以若採用該生物檢測技術分析戴奧辛毒
性當量，若樣品中含有未清除的重金屬，及有可能將低估戴奧辛的濃度，因此在進行
DRE-Luciferase bioassay 分析之前的淨化程序時，就必須將重金屬的干擾完全去除，避免干擾
戴奧辛的毒性當量的偵測。 
 
關鍵字：inhibition, 2,3,7,8-tetrachlorinated dibenzo-p-dioxn, MTT assay 
 
1. 前言 
鹵化之芳香族碳氫化合物如戴奧辛/呋喃(PCDD/Fs)與多氯聯苯(PCBs)是脂溶性的人造化
學物與毒性物質，在台灣這些有機氯化物遍佈於大氣、煙道氣、沉積物、魚類、血液與胎盤
與母乳中，因這些污染物在環境中具有累積性，這類的問題逐漸引起研究學者之重視，所以，
對於如何有效地監測環境、食物或人體中所含 PCDD/F、PCBs 的含量係刻不容緩。 
在過去十年來，檢測戴奧辛的方法以化學分析為主，一般而言，以高解析度氣相層析質
譜儀來進行分析，由於戴奧辛對於自然環境之毒害日受重視，自 1970 至 1993 年以來，投入
多氯戴奧辛與多氯呋喃毒性研究的經費，預估超過十億美金 [1]。化學分析所需之成本高、
時間長，在分析樣品日益增加的現代，已不合乎成本效益且不敷實際需求，因此，近年來，
藉由生物科技的幫助，發展出一系列的 in vitro bioassays 與 ligand binding assays，以檢測戴
奧辛及其類似物，更有歐美等國已公布戴奧辛生物偵測標準方法，例如美國環保署的 Method 
4025（Immunoassay） 與 Method 4425（Report gene assay），日本政府也於 2005 年公告 CALUX 
bioassay 為檢測戴奧辛之標準方法，在不久的將來採用 DRE-CALUX 成為快速檢測環境或食
  
1nM 2,3,7,8-TCDD搭配不同濃度之金屬溶液(0 ~ 100 μM)共同處理24小時，之後於每well添加
10μLMTT(5mg/mL.PBS)反應4小時，添加適當量DMSO溶解MTT結晶物質，以分光光度儀量
測595nm吸光值。 
 
3-3 Ethoxyresorufin-O-deethylase (EROD) assay (CYP1 A1 activity) 
採用方法係參考Behrens, et al.[18]與Donato, et al.[19]並加以修正過程，將Huh7-DRE-Luc
細胞以2×105/well種至12孔盤上並在隔夜之後，以不含血清之培養液配製1nM 2,3,7,8-TCDD搭
配不同濃度之金屬溶液 (0 ~ 20 μM) 共同處理 24 小時，之後將培養液更換為含
ethoxyresorufin(10μM) 與 dicourmarol(10μM) 之培養液反應 150 分鐘，最後將水解酵素
β-Glucuronidase/Arylsulfatase((20 Fish man units )/(160 Roy units))溶液與培養液混合反應30分
鐘，以黑色96孔盤於螢光儀量測螢光反應，以波長530 nm激發，量測590 nm波長之放射量，
CYP1A1活性以fluorescence light units (FLUs)為單位。 
 
3-4 DRE-CALUX生物檢測 (Luciferase activity) 
將Huh7-DRE-Luc細胞2.8×105/well種至種於12孔盤上並在隔夜之後，以不含血清之培養液
配製1nM 2,3,7,8-TCDD搭配不同濃度之金屬溶液(0 ~ 20 μM)共同處理24小時，經過處理後的
細胞，以150(μL/well) lysis buffer購自Promega (USA)將細胞收集並以冷凍解凍法打破細胞。測
定螢火蟲發光酵素活性參照商業化Luciferase Assay System 購自Promega (USA)並以白色96孔
微盤於冷光儀中進行螢火蟲發光酵素活性測量，設定儀器自動注入反應試劑100 μL/well並量
測反應時間10秒之冷光能量讀值，螢火蟲發光酵素活性單位則以relative light units (RLU)/μg 
protein表示，此外，以Bradford method(BioRad, USA)[20]做為蛋白質濃度定方法。 
 
3-5 數據分析 
單一金屬與2,3,7,8-TCDD共同處理實驗之各處理濃度皆以二重複進行，實驗次數為三或
四次，並以平均值±標準差(S.D.)表示來自各獨立實驗的據數整合，並以Student-t test分析空白
實驗(僅2,3,7,8-TCDD)與2,3,7,8-TCDD混合不同金屬處理間之數據差異，數據分析皆使用軟體 
Microsoft Excel計算。實驗設計中金屬與2,3,7,8-TCDD共同處理實驗之各處理濃度以二重複進
行，實驗結果取平均後以JMP5.0分析軟體計算。 
 
4 結果 
4-1 以2,3,7,8-TCDD(1nM)與不同濃度之NaAsO2、CdCl2、CrO3、HgCl2及PbCl2之無機金屬
溶液共處理下，對Huh7-DRE-Luc細胞之細胞生存率、CYP1A1酵素活性表現及螢火蟲發光酵
素活性表現 
 
4-1-1金屬NaAsO2：(圖4-1(A)) 
隨NaAsO2處理濃度增加細胞存活率遞減，NaAsO2濃度低於10-5M對細胞生存率並無明顯影
響且存活率大於80%，處理10-4M則有細胞毒性存活率明顯的下降至45%；隨NaAsO2處理濃度
增加CYP1A1活性則遞減，當處理低於10-6M CYP1A1活性未有明顯下降現象仍保持與控制組
相同反應活性，當NaAsO2濃度於10-5M則明顯的下降至30%；隨NaAsO2處理濃度增加螢火蟲
發光酵素活性則遞減，NaAsO2濃度於10-9M對螢火蟲發光酵素活性已有明顯降低現象，下降
程度約25%，當處理10-6M NaAsO2時螢火蟲發光酵素活性則已降低至40%。 
 
4-1-2金屬CdCl2：(圖4-1(B)) 
隨CdCl2處理濃度增加細胞存活率遞減，CdCl2濃度低於10-6M對細胞生存率並無明顯影響
且存活率大於80%，處理10-6M細胞毒性存活率則明顯的下降至80%；隨CdCl2處理濃度增加
  
PbCl2時螢火蟲發光酵素活性則已明顯下降至控制組反應活性之72%，然而，處理10-6M與10-5M
時螢火蟲發光酵素活性分別提高為81%與88%，處理10-6M時則又降低至控制組反應活性69%。 
 
4-2-2金屬As(CH3)2：(圖4-2(B)) 
隨As(CH3)2處理濃度增加細胞存活率未明顯降低反而增加細胞存活率，處理As(CH3)濃度
於10-10M~10-4M細胞存活率則高於控制組之6%~20%；隨As(CH3)2處理濃度增加CYP1A1活性
則遞減，當As(CH3)2濃度低於10-5M對CYP1A1活性並無明顯影響，當處理濃度於10-5MCYP1A1
活性仍保持與控制組相同反應活性之90%；隨As(CH3)2處理濃度增加螢火蟲發光酵素活性則
遞減，當As(CH3)2濃度於10-8M對螢火蟲發光酵素活性雖無明顯降低現象但下降程度已有
13%，當處理10-5M As(CH3)2時螢火蟲發光酵素活性則已明顯下降至控制組反應活性之75%。 
 
4-2-3金屬Hg(CH3)：(圖4-2(C)) 
當Hg(CH3)處理濃度低於10-6M時，隨Hg(CH3)處理濃度增加細胞存活率未明顯受到影響，
Hg(CH3)濃度於3×10-6M時細胞存活率雖無明顯下降但已低於控制組29%，Hg(CH3)濃度於5×
10-6M時細胞存活率則明顯下降於控制組之40%；隨Hg(CH3)處理濃度增加CYP1A1活性則遞
減，當 Hg(CH3) 濃度低於 10-9M 對 CYP1A1 活性並無明顯影響， Hg(CH3) 處理濃度於
10-6MCYP1A1活性仍保持與控制組相同反應活性之85%；隨Hg(CH3)處理濃度增加螢火蟲發光
酵素活性則遞減，當Hg(CH3)濃度於10-10M對螢火蟲發光酵素活性雖無明顯降低現象但下降程
度已有14%，當處理10-9M Hg(CH3)時螢火蟲發光酵素活性則明顯下降至控制組反應活性之
80%，10-6M Hg(CH3)時螢火蟲發光酵素活性則下降至控制組反應活性之72%。 
 
4-2-4金屬Pb(C2H5)4：(圖4-2(D)) 
當Pb(C2H5)4處理濃度低於10-5M時，隨Pb(C2H5)4處理濃度增加細胞存活率未明顯受到影
響，Pb(C2H5)4濃度於2×10-5M時細胞存活率則明顯下降低於控制組19%；當Pb(C2H5)4處理濃度
低於10-5M時，隨Pb(C2H5)4處理濃度增加CYP1A1活性未明顯受到影響，當Pb(C2H5)4濃度於2×
10-5M時CYP1A1活性則明顯下降低於控制組40%；當Pb(C2H5)4處理濃度於10-8M螢火蟲發光酵
素活性已明顯降低於控制組11%，處理10-6M Pb(C2H5)4時螢火蟲發光酵素活性則明顯下降至控
制組反應活性之74%，然而，處理10-5M與2×10-5M時螢火蟲發光酵素活性分別提高為82%與
76%。 
 
4-3  Factorial Design實驗設計 
實驗數據中與2,3,7,8-TCDD共同處理的包含無機金屬NaAsO2、CdCl2、CrO3、HgCl2及
PbCl2，有機金屬As(CH3)、As(CH3)2、Hg(CH3)及Pb(C2H5)4 兩類金屬所得之螢火蟲發光酵素
活性，而無論觀察實驗單一因子或實驗因子間的交互作用對質傳係數之影響，均需將各實驗
因子正規化（coded level）為-1 ~ +1，其表示方法如表4-1與表4-2。 
 將上述各實驗因子之水準配合矩陣之幾何對應排列，以產生實驗因子間之不同搭配組
合，藉此詳細瞭解各實驗因子與實驗因子間對於2,3,7,8-TCDD誘發螢火蟲發光酵素活性之影
響作深入探討，而經由實驗設計法所設計之操作條件與實驗所得之螢火蟲發光酵素活性列於
表4-3與表4-4，由各不同之實驗因子來觀察其對螢火蟲發光酵素活性之影響，並將實驗結果
利用最小平方法(Least Square Method)之統計多元迴歸(Multiple Regression)目標函數值即可得
到實驗因子對目標函數值的影響效應程度，其統計分析結果列於表4-5與表4-6，將相對影響
程度值與對應之實驗因子整理可得以下的數學式： 
 
 
 
 
  
外，推測是因細胞毒性而影響 DRE-Luciferase bioassay 的讀值，但在文獻[21]中之 MTT 測試
可說明，在重金屬低濃度的情況下對 Huh7-DRE-Luc 細胞株而言是不受細胞毒性影響的，因
此可屏除細胞毒性所造成之影響。文獻[23]所使用的細胞株是含有XRE-luciferase與 pGudLuc1
兩種質體穩定轉殖的細胞株(Hepa 1c1c7 cell)，雖與本研究使用的 Huh7-DRE-Luc 細胞株有所
不同，但 Hepa 1c1c7 細胞株對於以 2,3,7,8-TCDD 分別搭配三價砷、六價鉻的共同處理結果顯
示，三價砷、六價鉻基本上對於被 2,3,7,8-TCDD 誘發的反應亦是有抑制效果的，這也一再地
證實，在 DRE-CALUX 類似的系統中這些重金屬的確能夠顯著地降低因 TCDD 而產生的誘發
反應。另一方面本研究的實驗結果顯示以重金屬、2,3,7,8-TCDD 共同處理之螢火蟲發光酵素
反應皆明顯地小於僅以 2,3,7,8-TCDD 處理之，且隨著金屬的濃度增高，螢火蟲發光酵素反應
量逐漸減少，即處理劑量愈高所得結果卻愈低，表示測試的金屬皆有顯著的抑制因
2,3,7,8-TCDD 所誘發的基因表現。在低濃度 1μM 的情況下，由螢火蟲發光酵素下降的反應中
可得知，其抑制效果為 PbCl2 (42.40％)＞HgCl2 (56.03％)＞CrO3 (67.56％)，而文獻[24]也與本
研究得到相類似的一致性結果。 
另外，除了金屬物質如鉛、汞和鉻外，對於其他具脂溶性的污染物也需要特別注意，因
為這些物質常會對細胞產生細胞毒性。更重要的是，當這些脂溶性的物質與戴奧辛類似物要
以萃取、淨化的方式分離時，是很難做到完全分離的，這也勢必會增加以 DRE-Luciferase 
bioassay 生物檢測方法檢測戴奧辛與多氯聯苯毒性當量的困難度。如果以 DRE-Luciferase 
bioassay 應用於檢測含有戴奧辛類似物之環境樣品，例如像某南部地區的土壤中含有高濃度
的戴奧辛與汞，而汞則會使偵測的戴奧辛毒性當量有低估的情形，所以為了能正確地使用此
快速又低成本的檢測方法，上述提及的注意事項需做適當的考量。對於監測戴奧辛或戴奧辛
類似物的毒性當量多種不同的樣品基質中，本研究建議所檢測的數據可能會因樣品淨化的不
完全而含其他污染物如汞等重金屬而使得對所計算的 luciferase activity 值有低估的情況。 
 
自從人體血液、尿液和頭髮中檢測出高劑量的砷之後，這些在台灣受砷污染地區民眾的
健康備受重視，現今我們能以化學和生物的檢測方式準確地測出身體負荷的毒性當量程度。
然而，對於受金屬污染的地區因所檢測出的戴奧辛毒性當量程度而提出的人體健康影響可能
與戴奧辛濃度關聯性並不高，其可能係戴奧辛與金屬物質的整合性影響。基於本研究的結果，
我們建議對於受金屬與戴奧辛污染的地區中因戴奧辛與金屬物質雙重暴露所產生的健康影響
需要做更嚴謹的毒物學與流行病學的研究討論。  
 
 
6、參考文獻 
 
1. Vanden Heuvel, J.P. and G. Lucier, Environmental toxicology of polychlorinated 
dibenzo-p-dioxins and polychlorinated dibenzofurans. Environ Health Perspect, 1993. 100: 
p. 189-200. 
2. Windal, I., et al., Validation and Interpretation of CALUX as a Tool for the Estimation of 
Dioxin-Like Activity in Marine Biological Matrixes. Environmental Science & Technology, 
2005. 39(6): p. 1741-1748. 
3. Van Wouwe, N., et al., Importance of clean-up for comparison of TEQ-values obtained by 
CALUX and chemo-analysis. Talanta, 2004. 63(5): p. 1269-1272. 
4. Van Wouwe, N., et al., Validation of the CALUX bioassay for PCDD/F analyses in human 
blood plasma and comparison with GC-HRMS. Talanta, 2004. 63(5): p. 1157-1167. 
  
of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 1976. 
72(1-2): p. 248-254. 
21. Chao H.R., T.C. Tsou, L.A. Li, F.Y. Tsai, Y.F. Wang, “Arsenic inhibits induction  
    of cytochrome P450 1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatoma  
    cells,” J. Hazard. Mater. 2006, 137: p716–722. 
22. Chang E.E., Z.F. Miao, W.J. Lee, H.R. Chao, L.A. Li, “Arecoline inhibits the    
    2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1A1 activation in   
     human hepatoma cells,” J. Hazard. Mater. 2007, 146: p356-361.  
23. Reem H. Elbekai, Ayman O.S. El-Kadi, “Transcriptional activation and  
  posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium,”  
    Toxicol, 2007, 172: p106–119. 
24. Hesham M. Korashy and Ayman O. S. El-Kadi. “Regulatory Mechanisms Modulating  
    the Expression of Cytochrome P450 1A1 Gene by Heavy Metals,” Fundam  
    Toxicol Sci, 2005, 88(1): p39-51. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
(A)  (B)  
(C)  (D)  
圖 4-2、以 2,3,7,8-TCDD(1nM)與不同濃度之 As(CH3)、As(CH3)2、HgCH3 及 Pb(C2H5)4 之有機
金屬溶液共處理下，對 Huh7-DRE-Luc 細胞之細胞生存率、螢火蟲發光酵素活性表現及
CYP1A1 酵素活性表現，n=3 or 4，＊表示 p<0.05、＊＊表示 p<0.01 及＊＊＊表示 p<0.001，與僅處
理 2,3,7,8-TCDD(1 nM)作比較。 
 
 
  
表 4-3、無機金屬 NaAsO2、CdCl2、CrO3、HgCl2 及 PbCl2 與 2,3,7,8-TCDD(1nM)共處理對螢
火蟲發光酵素活性表現之 Factorial Design 實驗設計及實驗結果 
 NaAsO2 CdCl2 CrO3 HgCl2 PbCl2 Luciferase activity 
Trial No. (μM) (μM) (μM) (μM) (μM) ( RLU/ µg protein) % 
1 0 0 0 0 0 3158.11 100.0
2 0 0 0 0 1 1406.91 44.5
3 0 0 0 1 0 1778.05 56.3
4 0 0 0 1 1 889.01 28.2
5 0 0 1 0 0 839.25 26.6
6 0 0 1 0 1 468.26 14.8
7 0 0 1 1 0 695.95 22.0
8 0 0 1 1 1 358.67 11.4
9 0 0.1 0 0 0 2081.06 65.9
10 0 0.1 0 0 1 815.26 25.8
11 0 0.1 0 1 0 1206.61 38.2
12 0 0.1 0 1 1 592.03 18.7
13 0 0.1 1 0 0 555.09 17.6
14 0 0.1 1 0 1 362.24 11.5
15 0 0.1 1 1 0 422.58 13.4
16 0 0.1 1 1 1 270.27 8.6
17 1 0 0 0 0 1279.88 40.5
18 1 0 0 0 1 600.95 19.0
19 1 0 0 1 0 859.01 27.2
20 1 0 0 1 1 475.08 15.0
21 1 0 1 0 0 348.95 11.0
22 1 0 1 0 1 288.00 9.1
23 1 0 1 1 0 307.50 9.7
24 1 0 1 1 1 228.71 7.2
25 1 0.1 0 0 0 798.29 25.3
26 1 0.1 0 0 1 397.37 12.6
27 1 0.1 0 1 0 586.94 18.6
28 1 0.1 0 1 1 390.52 12.4
29 1 0.1 1 0 0 280.24 8.9
30 1 0.1 1 0 1 191.73 6.1
31 1 0.1 1 1 0 222.67 7.1
32 1 0.1 1 1 1 176.72 5.6
 
 
  
表 4-5 實驗設計無機金屬對螢火蟲發光酵素活性迴歸模式之迴歸參數 
Factor Coefficient T value Prob>|t| 
Intercept 23.0875 168.4319 0.000035 
As -8.3813 -61.1443 0.000267 
Cd -4.5688 -33.3307 0.000899 
Cr -11.1750 -81.5258 0.000150 
Hg -4.3625 -31.8261 0.000986 
Pb -7.4313 -54.2137 0.000340 
As*Cd 1.9375 14.1348 0.004968 
As*Cr 4.5563 33.2395 0.000904 
As*Hg 2.5063 18.2840 0.002978 
As*Pb 3.6000 26.2633 0.001447 
Cd*Cr 2.5063 18.2840 0.002978 
Cd*Hg 1.1688 8.5265 0.013478 
Cd*Pb 1.5750 11.4902 0.007489 
Cr*Hg 3.0750 22.4333 0.001981 
Cr*Pb 4.8063 35.0634 0.000812 
Hg*Pb 2.0938 15.2747 0.004259 
As*Cd*Cr -1.0375 -7.5689 0.017011 
As*Cd*Hg -0.4625 -3.3741 0.077734 
As*Cd*Pb -0.6438 -4.6964 0.042471 
As*Cr*Hg -1.9063 -13.9068 0.005131 
As*Cr*Pb -2.0625 -15.0467 0.004388 
As*Hg*Pb -1.0625 -7.7513 0.016239 
Cd*Cr*Hg -1.0563 -7.7057 0.016427 
Cd*Cr*Pb -0.8500 -6.2011 0.025033 
Cd*Hg*Pb -0.2375 -1.7327 0.225296 
Cr*Hg*Pb -1.8938 -13.8156 0.005198 
As*Cd*Cr*Hg 0.4625 3.3741 0.077734 
As*Cd*Cr*Pb -0.0688 -0.5016 0.665745 
As*Cd*Hg*Pb 0.9500 6.9306 0.020191 
As*Cr*Hg*Pb 0.3625 2.6446 0.118170 
As*Cd*Cr*Hg*Pb 0.0688 - - 
 
 
 
 
 
 
 
This article appeared in a journal published by Elsevier. The attached
copy is furnished to the author for internal non-commercial research
and education use, including for instruction at the authors institution
and sharing with colleagues.
Other uses, including reproduction and distribution, or selling or
licensing copies, or posting to personal, institutional or third party
websites are prohibited.
In most cases authors are permitted to post their version of the
article (e.g. in Word or Tex form) to their personal website or
institutional repository. Authors requiring further information
regarding Elsevier’s archiving and manuscript policies are
encouraged to visit:
http://www.elsevier.com/copyright
Author's personal copy
352 H.-R. Chao et al. / Journal of Hazardous Materials 170 (2009) 351–356
dioxin bioassay has been widely used to detect CALUX-TEQ levels
in variousmatrices, such as ﬁsh [8], breast milk [9], sediments [10],
andwater efﬂuents [11]. A high correlation coefﬁcient (r=0.91)was
found between CALUX-TEQ and dioxin-World Health Organization
(WHO)-TEQ levels in retail ﬁsh [8]. Compared to a high-resolution
gas chromatograph equipped with a high resolution mass detec-
tor (HRGC/HRMS), the DRE-CALUX bioassay has the advantages of
shorter time requirement and lower cost. In addition, the DRE-
CALUX bioassay may be a good screening method for dioxin
surveillance.
The systems of DRE-CALUX are established in the recombi-
nant mouse (Xenobiotic Detection System, Inc.) or rat hepatoma
(BioDetection System b. v.) cells. In our previous study [12], we
set up a stable system of a DRE-driven luciferase reporter gene in
genetically modiﬁed human hepatoma cells (Huh7-DRE-Luc cells).
It has been reported that a non-aryl hydrocarbon receptor (AhR)
ligand, such as arsenic [12] or arecoline [13], interferes with TCDD-
induced luciferaseactivation inHuh7-DRE-Luccells. It hasalsobeen
reported that sodium arsenite, cadmium chloride, and chromium
trioxide could induce luciferase activities in Hepa 1c1c7 cells tran-
siently transfected with a xenobiotic-responsive element-driven
luciferase reporter gene [14]. Furthermore, the analytical results
of the DRE-CALUX bioassay are probably correlated with extensive
cleanup procedures due to the absence of spiked internal standards
and the contaminants, particularly for unknown AhR agonists and
antagonists, in solvents and samples [15]. The DRE-CALUX bioas-
say may require further improvement for application in various
matrices and ﬁeld surveillance.
The dioxin-induced cytochrome P450 1A1 (CYP1A1) enzyme
activity in an EROD bioassay and DRE-CALUX has been widely
applied in various samples [16]. The induction fold, limit of detec-
tion, and limit of quantiﬁcation were found to be similar for the
DRE-CALUX and EROD bioassays by testing several dioxins and
dioxin-like compounds in two rat hepatoma H4II cell lines [16].
Several studies have reported that metals (i.e. cadmium) can mod-
ify CYPs functions [17]. There was a signiﬁcant dose-dependent
induction of CYP1A1 in the hepatoma (HepG2) cell lines caused by
Cd2+ in concentrations from 1.25 to 15M [18]. Elbekai and El-Kadi
[17] co-administered Cd2+ with AhR ligand to inhibit the induction
of CYP1A1 activation and to increase its mRNA levels and protein
expression in Hepa 1c1c7 cells.
In previous studies, Chen et al. [19] found high amounts of Cd
in the sediment by calculating its enrichment factors (EFs) ranged
from3.0 to 36.1. Liao et al. [20] investigated themetal distribution in
the Nanjing area and found that the EF of Cd was 1.51. These results
show that Cd is a prevalent environmental contaminant. It is also
commonly found in high levels in groundwater [21] and in themale
populationwith a smoking habit in Taiwan [22]. The ﬁndings of our
previous study showed that sodium arsenite (As3+) inhibited the
induction of CYP1A1by2,3,7,8-TCDD inbothhumanhepatoma cells
(Huh7) and recombinant Huh7-DRE-Luc cells [12]. The study sug-
gested that extensive cleanup prevents any possible interference
and guarantees the accuracy of the Huh7-DRE-Luc bioassay [12]. In
this study, we examined the inhibitory effect of cadmium cations
on the activation of Huh7-DRE-Luc and CYP1A1 enzyme activity in
human hepatoma cell (Huh7) lines to further understand how cad-
mium inﬂuences the response of the Huh7 cell line while applying
it in Cd–PCDD/Fs co-contaminated environmental samples.
2. Methods and materials
2.1. Materials and reagents
Cadmium chloride and 2,3,7,8-TCDDwere purchased from Fluka
Chemie GmbH (Buchs, Switzerland). Ethoxyresoruﬁn, resoruﬁn,
salicylamide, and dimethyl sulfoxide (DMSO)were purchased from
Sigma–Aldrich (St. Louis, MO, USA). 3-(4,5-Dimethyl-2-thiazolyl)-
2,5-diphenyl-2H tetrazolium bromide (MTT) was obtained from
Calbiochem (San Diego, CA, USA). The 4xDRE-TATA-Luc plasmid
was constructed by cloning four copies of DRE of human CYP1A1
(DREs: −499, −895, −983, and −1056) [23] prior to a TATA box and
a ﬁreﬂy luciferase gene. The human hepatoma cell line Huh7 and
the pSUPER-EGFP-neor vector carrying EGFP with neor genes were
respectively provided by Dr. Chiung-Tong Chen and Dr. Chi-Ying F.
Huang (National Health Research Institutes, Taiwan). Quantiﬁca-
tion of protein concentration was determined using the Bradford
method (BioRad, Hercules, CA, USA) [24].
2.2. Measurements of luciferase activation in recombinant
Huh7-DRE-Luc cells
Stable transfection followed a previously described [7] proce-
dure with slight modiﬁcations. Stable and available Huh7-DRE-Luc
cells were established as described in detail in our previous report
[12]. In brief, Huh7 cells seeded in 60mm dishes were transfected
with a reporter vector (4xDRE-TATA-Luc) and a selection vector
(pSUPER-EGFP-neo), respectively. After 2 days of growth in anonse-
lectivemedium, the transfected cellswere re-plated into a selection
medium containing 800 and 200g/ml G418 for 1 week and 1
month, respectively. The Huh7-DRE-Luc cell clone was selected for
the best inducible activations of DRE-luciferase activity by 2,3,7,8-
TCDD from 45 individual clones (35 Huh7 and 10 HepG2 clones).
The clones were continuously incubated for 14 months with stable
DRE-luciferase activity.
The analytical method of the DRE luciferase bioassay was
described in detail previously [12]. For analysis of the cadmium
effect on TCDD-induced DRE luciferase activation, the cells were
treated with 10nM 2,3,7,8-TCDD for 24h in various cadmium chlo-
ride concentrations (1, 5, and 25M). After treatments, cell lysates
were collected in 0.2ml of reporter lysis buffer (0.1 KH2PO4, pH
7.9, 0.5% Triton X-100, and 1mM DTT) and then frozen-thawed at
least three times to assure complete cell lysis. Luciferase activities
fromHuh7-DRE-Luccellsweremeasuredusing theLuciferaseAssay
System (Promega, Madison, WI, USA) with relative light units of
(RLU)/g protein.
2.3. Cell viability assay
For the cytotoxicity tests, Huh7 cells were seeded in a 96-well
plate at a density of 4×104/well and cultured in DMEM (Dul-
becco’s modiﬁed Eagle’s medium) for 24h. The Huh7 cells were
then treated with Cd2+ (1.0, 5.0, and 25M) for another 24h or
left untreated. Cell viability was determined using the MTT assay,
following a previously described procedure [25].
2.4. CYP1A1 activity determined using the EROD assay
The EROD bioassay with human hepatoma Huh7 cells was per-
formed as described in Ref. [26]. Huh7 cells were seeded into
24-well cell culture plates up to a density of 90% conﬂuence in the
medium. Cells were treated for 24h with 10nM 2,3,7,8-TCDD and
Cd2+ (1.0, 5.0, and 25M) or with just 10nM 2,3,7,8-TCDD. After
treatment, the medium was removed and the well was washed
twicewith freshmediumat the endof the incubation. ERODactivity
was determined as described in Ref. [27] using 5M of ethoxyre-
soruﬁn in DMEM medium as the substrate of the CYP1A1 enzyme
with 1.5mM of salicylamide to inhibit enzyme conjugation. After
an incubation of 30min at 37 ◦C, ﬂuorescence was measured using
a Fluoroskan multi-well ﬂuorescence plate reader (Labsystems).
Resoruﬁn standard curves were used to convert ﬂuorescence to
p moles of resoruﬁn formed. The CYP1A1 activity was deﬁned as
resoruﬁn formation (in p moles) per 100min of reaction time (p
Author's personal copy
354 H.-R. Chao et al. / Journal of Hazardous Materials 170 (2009) 351–356
Fig. 2. Inhibitory effect of cadmium on TCDD-induced CYP1A1 activation in Huh7
cells (IC50 = 23.2M Cd2+). The cells were treated with 10nM TCDD in the presence
of different concentrations of Cd2+ (1, 5, and 25M) for 24h and without it. CYP1A1
activities are presented as mean± SD, n=3, and are expressed as relative CYP1A1
activity (%). *p<0.05, comparedwith the relative untreated control (with or without
10nM TCDD).
Cd2+ for Huh7 cells, which are the parental cells of Huh7-DRE-Luc
cells, for the estimate of Cd2+ effects on luciferase activation by
2,3,7,8-TCDD. Huh7 cellswere treatedwith various Cd2+ concentra-
tions for 24h. The survival rate of the cells was determined using
the MTT assay to analyze the cytotoxic effect of Cd2+. Concentra-
tions of Cd2+ ≥1M caused cytotoxic effects with decrease in the
survival rate of 89–84% (p<0.001), as shown in Fig. 3. The relative
survival rates of treatments with 5 and 25M Cd2+ were not sig-
niﬁcantly lower than that with 1M of Cd2+ (p>0.05). Although
slightly cytotoxic effects were found in Huh7 cells treated with
≥1M Cd2+, they did not signiﬁcantly affect the performance of
Huh7 and Huh7-DRE-Luc cells using the EROD and DRE luciferase
bioassays, respectively. We also evaluated the cytotoxicity of Cd2+
in the presence of TCDD to consider the combined effects in Huh7
cells. Huh7 cells were also treated with Cd2+ with 10nM TCDD for
24h. Our data indicate that the presence of TCDD and Cd2+ treat-
ments exhibits nomarked cytotoxicity in the survival rate (data not
shown). Additionally, Huh7-DRE-Luc cells for cytotoxicity testwere
also performed. The result indicated that there was no signiﬁcant
difference for cytotoxicity between metal alone and cotreatment
test (data not shown).
Fig. 3. The cytotoxic effect of cadmium on Huh7 cells. The cells were left untreated
orwere treatedwith different concentrations of Cd2+ (1, 5, and 25M) for 24h. After
treatments, survival rates were determined using theMTT assay. Data are presented
as mean± SD, n=3, and are expressed as percentage of survival rate compared to
that of the untreated control. *p<0.05, comparedwith the relative untreated control
(with or without 10nM TCDD).
4. Discussion
Cadmium (II) chloride signiﬁcantly inhibited TCDD-induced
luciferase activation in a dose-dependent manner, as shown in
Fig. 1. Few studies have indicated that heavy metals could inter-
fere with TCDD-induced DRE-luciferase activities in recombinant
hepatoma cells. According to our previous study [12], concentra-
tions of sodium arsenite (NaAsO2) higher than 3M signiﬁcantly
inhibited TCDD-induced luciferase activation in Huh7-DRE-Luc
cells. Treatment with Cd2+ inhibited both TCDD-induced luciferase
(Huh7-DRE-Luc cells) (Fig. 1) and EROD (Huh7 cells) (Fig. 2) acti-
vation in a dose-dependent manner without signiﬁcantly affecting
cytotoxicity in Huh7 cells (Fig. 3).
We found that Cd2+ alone did not have signiﬁcant toxic effects
on CYP1A1 and DRE luciferase activation in either cell after the rel-
ative survival rates of cytotoxic effects were adjusted (p>0.05). The
results of some studies were consistent with ours, but those of oth-
ers were not. Hepa 1c1c7 treated with 5M Cd2+ did not show an
inducible effect on EROD activities [28]. HepG2 treated with 5M
cadmium chloride was not signiﬁcantly different compared with
the untreated control [27]. In in vitro studies with Cd2+ treatment
ranging from 0 to 26.7M [29] and 0 to 15M [18], a signiﬁcant
Table 2
Inhibitory effect of cadmium on TCDD-induced CYP1A1 activation in Huh7 cells (p mole resoruﬁn/100min).
Cadmium chloride concentration 0M 1M 5M 25M p-Valuea p-Valueb
10nM TCDD+Cd2+ (n=3) 0.007 0.033
Mean 56.0 66.5 55.9 26.8 – –
95% C.I.c 51.6–60.3 49.9–83.0 44.1–67.6 11.1–42.5 – –
p-Valued – 0.400 0.700 0.043 – –
Cd2+ alone (n=3) 0.553 0.570
Mean± SE 12.9 15.8 14.4 11.1 – –
95% C.I.c 6.12–19.6 11.1–20.6 9.06–19.8 8.01–14.3 – –
p-Valued – 0.400 0.700 0.700 – –
Nonparametric tests
p-Valuee <0.001 <0.001 <0.001 <0.001
a ANOVA tests.
b Jonkheere–Terpstra tests.
c 95C.I. means 95% of conﬁdence interval.
d Mann–Whiney U-tests comparing the untreated control to the cotreatment of Cd2+ and TCDD.
e The signiﬁcant differences in EROD activities between the cotreatment and the treatment alone were examined using Moses extreme reaction tests.
Author's personal copy
356 H.-R. Chao et al. / Journal of Hazardous Materials 170 (2009) 351–356
[16] P.A. Behnisch, K. Hosoe, A. Brouwer, S. Sakai, Screening of dioxin-like toxicity
equivalents for various matrices with wildtype and recombinant rat hepatoma
H4IIE cells, Toxicol. Sci. 69 (2002) 125–130.
[17] R.H. Elbekai, A.O.S. El-Kadi, Modulation of aryl hydrocarbon receptor-regulated
gene expression by arsenite, cadmium, and chromium, Toxicology 202 (2004)
249–269.
[18] D.B. Tully, B.J. Collins, J.D. Overstreet, C.S. Smith, G.E. Dinse, M.M. Mumtaz, R.E.
Chapin, Effects of Arsenic, cadmium, chromium, and lead on gene expression
regulated by a battery of 13 different promoters in recombinant HepG2 cells,
Toxicol. Appl. Pharmacol. 168 (2000) 79–90.
[19] C.-W. Chen, C.-M. Kao, C.-F. Chen, C.-D. Dong, Distribution and accumulation of
heavy metals in the sediments of Kaohsiung Harbor, Taiwan, Chemosphere 66
(2007) 1431–1440.
[20] Q.-l. Liao, L.J. Evans, X. Gu, D.-f. Fan, Y. Jin, H.Wang, A regional geochemical sur-
vey of soils in Jiangsu Province, China: preliminary assessment of soil fertility
and soil contamination, Geoderma 142 (2007) 18–28.
[21] L.-j. Tsai, K.-c. Yu, S.-T. Ho, Cadmium distribution in sediment proﬁles of the six
main rivers in southern Taiwan, J. Hazard. Mater. 148 (2007) 630–639.
[22] Y.C. Chen, Y.S. Pu, R.S. Lin, C.Y. Yang, M.K. Lai, S.H. Liu, F.C. Sung, Blood and urine
cadmium levels in relation to demographic and life style in middle aged and
elderly men, Bull. Environ. Contam. Toxicol. 66 (2001) 287–294.
[23] S. Kress, J. Reichert, M. Schwarz, Functional analysis of the human cytochrome
P4501A1 (CYP1A1) gene enhancer, Eur. J. Biochem. 258 (1998) 803–812.
[24] M.M. Bradford, A rapid and sensitive method for the quantitation of micro-
gram quantities of protein utilizing the principle of protein-dye binding, Anal.
Biochem. 72 (1976) 248–254.
[25] T.C. Tsou, S.C. Yeh, F.Y. Tsai, L.W. Chang, The protective role of intracellular GSH
status in the arsenite-induced vascular endothelial dysfunction, Chem. Res.
Toxicol. 17 (2004) 208–217.
[26] E.E. Chang, Z.-F.Miao,W.-J. Lee, H.-R. Chao, L.-A. Li, Y.-F.Wang, Y.-C. Ko, F.-Y. Tsai,
S.C. Yeh, T.-C. Tsou, Arecoline inhibits the 2,3,7,8-tetrachlorodibenzo-p-dioxin-
induced cytochrome P450 1A1 activation in human hepatoma cells, J. Hazard.
Mater. 146 (2007) 356–361.
[27] S.W. Kennedy, S.P. Jones, Simultaneous measurement of cytochrome P4501A
catalytic activity and total protein concentration with a ﬂuorescence plate
reader, Anal. Biochem. 222 (1994) 217–223.
[28] R.H. Elbekai, A.O.S. El-Kadi, The role of oxidative stress in themodulation of aryl
hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+, Free Radic. Biol.
Med. 39 (2005) 1499–1511.
[29] P.F. Dehn, C.M. White, D.E. Conners, G. Shipkey, T.A. Cumbo, Characterization
of the human hepatocellular carcinoma (hepg2) cell line as an in vitro model
for cadmium toxicity studies, In Vitro Cell Dev. Biol. Anim. 40 (2004) 172–
182.
[30] R.H. Elbekai, J. Duke, A.O.S. El-Kadi, Ascorbic acid differentially modulates the
induction of heme oxygenase-1, NAD(P)H:quinone oxidoreductase 1 and glu-
tathione S-transferase Ya by As3+, Cd2+ and Cr6+, Cancer Lett. 246 (2007) 54–62.
※報告內容請包括下列各項，並以 A4 紙書寫。 
 
一、 參加會議經過 
2009 年的歐洲氣膠研討會由歐洲氣膠聯盟  (European Aerosol Assembly)的 Gesellschaft 
fur Aerosolforschung (GAeF)和 Karlsruhe 大學(University of Karlsruhe)共同主辦，在德國
-Karlsruhe 大學舉行，會議時間從 09 月 06 日至 09 月 11 日，總計六日。本次研討會總計超
過 700 篇論文發表，與會人士每日約 600~700 多人，國內亦有多人參與本研討會，如台灣大
學陳志傑教授、中央大學林能暉教授和李崇德教授、成功大學李文智教授及其研究生、屏科
大陳瑞仁教授、北科大林文印教授、高雄應用科大蔡政賢教授、嘉南藥理科技大學蔡瀛逸教
授以及正修科大王琳麒教授等人。 
歐洲氣膠研討會每年由歐洲氣膠會員輪流舉辦，是氣膠領域重要的學術交流活動，因此
也吸引全球從事氣膠研究之專家學者與會，發表並討論氣膠科技之研究成果與最新發展。論
文主題涵蓋廣泛，包括：氣膠化學與物理、奈米氣膠產生與過濾技術、氣膠動力學、氣膠吸
溼特性與雲霧凝結核、氣膠光學特性、都會氣膠、採樣技術、模式與數值模擬、氣膠管制標
準研擬、放射性氣膠、極地與海洋氣膠、生物氣膠、燃燒氣膠、高溫氣膠、工業氣膠、奈米
氣膠、核子氣膠、製藥粉末氣膠、氣體清淨與分離技術、大氣及室內氣膠、氣膠靜電效應、
氣膠傳輸及沉降、氣膠環境影響、氣膠之健康效應、粗大塵粒，以及氣膠儀器發展等多項領
域。 
    每天議程除了口頭論文報告外，均安排一場國際知名氣膠學者發表專題演講，大會邀請
之專題演說者包括 Prof. Aladar Czitrovski, Prof. Heinz Burtscher, Prof. Wolfgang G. Kreyling, 
Prof. Gerhard Kasper, Prof. Mats Bohgard 等氣膠研究領域之傑出學者，發表其氣膠研究之主要
成果。Prof. Thomas Kuhlbusch 主要發表氣膠曝露和健康之關係 (Aerosol exposure and health 
effects: Do we know the basis?)；Prof. Werner Hofmann 模擬氣膠沈降 (Modelling inhaled 
paeticle deposition in the human lung); Prof. Matti Maricq 說明汽車排氣和氣膠減量之議題
（Automotive emissions and how aerosol science contributes to reducing them）等。專題演講安
排於 Karlsruhe 大學會議廳舉行，聽眾參與非常踴躍，每場幾乎座無虛席，室內環境整齊典雅，
讓人感受到置身於崇高之學術殿堂內甚感收穫良多。 
 
少，而Andersen六階採樣器採樣結果發現菌落多集中於第一階(>7 μm)與第五階(2.1-1.1μm)。
此外，一般認為鼻腔可過濾10μm以上之生物性氣膠，而10-4μm的生物性氣膠可被氣管去除，
小於3μm會對支氣管及肺泡造成影響，由此可推測若吸入第一階上生長之微生物，對鼻咽部
可能有比較顯著的影響，而若吸入第四階至第六階上生長之微生物，將有較大的機會沉積
於支氣管或肺泡中，而第五階層所佔比例不論在細菌或真菌皆為優勢比例，因此第五階層
上微生物種類更值得我們進一步探討。高濃度之生物氣膠濃度和過敏或氣喘的相關性，對
人體是否造成潛在性傷害，仍有待進一步之研究與國內外學者之指正，以求研究成果之突
破與進展。但看到會場許多論文引起熱烈的迴響與諸多的討論，仍予報告人留下深刻之印
象，並且獲得諸多啟發，並感受到寶貴經驗交流之重要性。在會場中遇到Dr. Zaheer，對我
的data提供許多寶貴的建議，對於個人之研究有極豐富的啟發及研究助益，非常感謝國家和
學校提供這樣的機會。 
 
 
三、 考察參觀活動 
此次研討會主辦單位在 9 月 9 日下午，安排一場實驗室參觀和陶瓷工廠導纜，
Forschungszentrum Karlsruhe Institute of Technology (KIT) 是歐洲最大的科學和工程研究單
位，研究聚焦於材料、環境、健康、能源和專利科技。其設計的 AIDA 系統可觀察大氣中
氣膠異相化學的變化，另外 PMS 系統，可量測火焰和電漿中小於 0.5 nm 的奈米顆粒，更值
得一提的是，Karlsruhe Exposure System 是一個模擬人體曝露的移動式設備，模擬肺臟細胞
直接曝露於污染源後，再進行毒性測試等，在現今污染物暴露評估的實驗上位居翹楚。 
 
四、建議 
本次參與 2009 年歐洲氣膠研討會會議，成果豐碩，除與國內外與會之專家學者交換研
究心得外，也吸取很多寶貴經驗與想法，建議國內之專家學者多能在參與多國舉辦之國際
研討會後，貢獻經驗提供國內的國際氣膠研討會籌備參考。有感於研究不能閉門造車，應
多與各國之研究學者專家交流，才能以獲裨益，建議仿傚以往研討會之會議期初所安排的
教學課程，使國內有志從事氣膠研究之年輕後輩，除學校課程與參與研討會外，能進一步
在研討會中學習氣膠理論基礎及實務之機會。 
